Use of Ctdna in Patients With Gastrointestinal Tract Tumors
NCT06202131 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-09-02
Summary
This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.
Conditions
- Pancreas Cancer
- Colon Cancer
- Biliary Tract Cancer
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Lisa Sakvatore, MD, PhD · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2028-11-01
- Completion
- 2028-11-01
Countries
- Italy
Study Locations
More Related Trials
-
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
NCT04530890 ·Status: RECRUITING ·Phase: NA
-
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517 ·Status: RECRUITING
-
Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)
NCT02443948 ·Status: UNKNOWN
-
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372 ·Status: UNKNOWN
-
Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
NCT06877910 ·Status: ACTIVE_NOT_RECRUITING
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
NCT02612350 ·Status: COMPLETED
-
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT05630131 ·Status: COMPLETED
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
NCT07142226 ·Status: RECRUITING
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN
-
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
NCT07151118 ·Status: RECRUITING
-
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
NCT06076070 ·Status: UNKNOWN
-
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
NCT03749083 ·Status: WITHDRAWN
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
NCT06653127 ·Status: RECRUITING
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
NCT06589388 ·Status: RECRUITING
-
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326 ·Status: COMPLETED
-
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NCT03305146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients
NCT05254821 ·Status: RECRUITING
-
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
NCT04920513 ·Status: COMPLETED
-
Molecular Genetic and Pathological Studies of Anal Tumors
NCT00267787 ·Status: TERMINATED
-
Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
NCT05379907 ·Status: WITHDRAWN
-
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
NCT06290856 ·Status: TERMINATED
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN